Related Experiment Video
Updated: May 23, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Clinical Significance of Bone Metastases in Pleural Mesothelioma
Mitsutomi Miyake1, Kozo Kuribayashi1, Hiroshi Doi2
1Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Japan.
Background:
Bone metastasis (BoM) is common in advanced cancer, but its incidence in pleural mesothelioma (PM) remains unclear. This study aimed to determine the incidence of BoM in PM patients and assess its prognosis and risk factors to clarify its clinical significance.
Methods:
A retrospective analysis was conducted on 515 histologically confirmed PM patients enrolled between January 2011 and December 2020. The cumulative incidence of BoM was calculated using the Kaplan-Meier method, with group differences assessed via log-rank tests. Risk factors for BoM were evaluated using multivariate logistic regression.
Results:
The median follow-up was 13.3 months (range: 0.2-106.7 months). BoM was detected in 59 patients (11.5%) at diagnosis or during disease progression. Multivariate analysis identified non-epithelial histology (odds ratio [OR]: 2.189, 95% confidence interval [CI]: 1.179-4.065, p = 0.013) as an independent risk factor for developing BoM. Patients with BoM had worse overall survival (OS) compared to those without BoM (median OS: 18.6 months vs. 21.7 months, p = 0.03).
Conclusions:
BoM in PM occurs less frequently than in primary lung cancer, with non-epithelial histology being more commonly associated with BoM. Patients with BoM had a poor prognosis, particularly when BoM was present at diagnosis. This study is limited by its retrospective design, which may introduce biases related to data collection and patient selection. Future prospective studies are needed to validate these findings.
Insights
Bone metastasis (BoM) occurs in 11.5% of pleural mesothelioma (PM) patients, with non-epithelial histology being a risk factor. Patients with BoM face a poorer prognosis, highlighting the clinical significance of bone metastasis in PM.
Area of Science:
- Oncology
- Thoracic Surgery
- Pathology
Background:
- Bone metastasis (BoM) is a frequent complication in advanced cancers.
- The incidence and clinical significance of BoM in pleural mesothelioma (PM) are not well-established.
- Understanding BoM in PM is crucial for patient management and prognosis.
Purpose of the Study:
- To determine the incidence of BoM in patients with pleural mesothelioma.
- To identify risk factors associated with the development of BoM in PM.
- To evaluate the prognostic impact of BoM on overall survival in PM patients.
Main Methods:
- Retrospective analysis of 515 histologically confirmed PM patients (2011-2020).
- Kaplan-Meier method for cumulative incidence calculation.
- Multivariate logistic regression to identify risk factors for BoM.
Main Results:
- BoM was diagnosed in 11.5% of PM patients, either at initial diagnosis or during progression.
- Non-epithelial histology was identified as an independent risk factor for BoM (OR: 2.189).
- Patients with BoM exhibited significantly worse overall survival (median 18.6 months vs. 21.7 months).
Conclusions:
- BoM is less frequent in PM than in lung cancer, but associated with non-epithelial histology.
- The presence of BoM portends a poor prognosis for pleural mesothelioma patients.
- Further prospective studies are warranted to confirm these findings due to the retrospective nature of this study.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pleura of the Lungs
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumothorax-II
Clinical Manifestations:

